Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., Ltd. was established in February 2004 and is located in the Life Science Park of Zhongguancun, Beijing. It covers an area of approximately 99 acres and is the only wholly-owned subsidiary of Yangzijiang Pharmaceutical Group in the north for research and development and production. Over the past decade, Beijing Haiyan has rapidly developed into a high-tech and high growth enterprise that integrates production, research and development, and market promotion. It has been recognized as a high-tech enterprise by the Beijing Municipal Science and Technology Commission, one of the first batch of outstanding growth enterprises selected for the G20 Project of the Beijing Biomedical Industry Leaping Development Project, a major high-tech achievement transformation project base in Beijing, and the Beijing Respiratory Disease Drug Engineering Technology Research Center, 2019 Beijing Green Manufacturing Demonstration Enterprise, National Green Manufacturing Demonstration Enterprise, Beijing Integrity Creation Enterprise, Beijing Enterprise Technology Center, 2019 Excellent Enterprise Brand for Promoting the Integration of Industrialization and Industrialization in China's Chemical and Pharmaceutical Industry, 2019 Top 100 Comprehensive Practical Enterprises in China's Chemical and Pharmaceutical Industry, 2019 Beijing Enterprise Evaluation Association Science and Technology Innovation Award - Science and Technology Innovation Enterprise, and the first batch of "specialized, refined, and new" small giant enterprises in Beijing in 2020 There are many honors such as the National High tech Enterprise in 2020, the Excellent Enterprise Brand in Promoting the Integration of Industrialization and Industrialization in the Chinese Chemical and Pharmaceutical Industry in 2020, the Integrity Great Wall Cup Enterprise in 2021, Changping District Science and Technology Research and Development Institute, and the Star Party Branch of Zhongguancun Life Science Park.

The company attaches great importance to innovative research and development, and has achieved fruitful results. At present, the main products that have been launched include Suhuang cough relieving capsules, Cosu (Irbesartan tablets), racecadotrexate tablets, Baiai capsules, benzoic acid lizatriptan tablets, hydrochloric acid memantine tablets, celecoxib capsules, and other advantageous fields such as respiratory system and cardiovascular system.

Among them, Suhuang Zhike Capsules, Kesu (Irbesartan Tablets), and Benzoate Lizatriptan Tablets have all obtained the Beijing New Technology and New Product (Service) Certificate. The Beijing Haiyan Maqin Granule Process Development and Achievement Transformation Project received funding support for the 2019 Zhongguancun Demonstration Zone Major High Precision and Advanced Achievement Industrialization Project (in the field of pharmaceuticals and medical devices), and Kesu (Irbesartan Tablets) received funding in 2019 The 2021 Beijing Enterprise Evaluation Association Science and Technology Innovation Award and the 2021 China Chemical Pharmaceutical Industry Blood Pressure Lowering Excellent Product Brand.

Faced with future tasks and challenges, Beijing Haiyan will continue to uphold the mission of "seeking progress and protecting all sentient beings", forge ahead and never be satisfied, and contribute to the people's medical and health cause.